infectious disease

https://pharmaphorum.com/events/cell-mediated-therapies-for-infectious-disease-summit/

ViiV’s Rukobia cleared in EU as rescue HIV therapy

https://pharmaphorum.com/news/viivs-rukobia-cleared-in-eu-as-rescue-hiv-therapy/

EUSA Pharma hopes IL-6 drug will succeed in COVID-19 where rivals failed

https://pharmaphorum.com/news/eusa-pharma-hopes-il-6-drug-will-work-in-covid-19-where-class-rivals-failed/

Data sets up 2021 filings for Gilead’s twice-a-year HIV drug lenacapavir

https://pharmaphorum.com/news/data-sets-up-2021-filings-for-gileads-twice-a-year-hiv-drug-lenacapavir/

Adult data back Merck & Co’s challenger to Pfizer’s blockbuster Prevnar 13

https://pharmaphorum.com/news/adult-data-back-mercks-challenger-to-pfizers-blockbuster-prevnar-13/

Scynexis bids to end novel antifungal drought, filing ibrexafungerp in US

https://pharmaphorum.com/news/scynexis-bids-to-end-novel-antifungal-drought/

COVID-19 vaccine could be ready in time for US elections

https://pharmaphorum.com/news/covid-19-vaccine-could-be-ready-in-time-for-us-elections/

Ionis deal delivers for GSK as HBV drug hits the mark in phase 2

https://pharmaphorum.com/news/ionis-deal-delivers-for-gsk-as-hbv-drug-hits-the-mark-in-phase-2/

Novo-backed $61m fundraising helps F2G prep for antifungal launch

https://pharmaphorum.com/news/novo-backed-61m-fundraising-helps-f2g-prep-for-antifungal-launch/

1 2 3 4 5

Close in 10 seconds

Pharmaphorum.com

Search